Free abscisic acid (ABA) in integuments, nucellus, endosperm, and embryo was determined throughout seed development of peach (Prunus persica L. cv Springcrest). Quantification of ABA was performed using combined high performance liquid chromatography-radioimmunoassay based on a monoclonal antibody raised against free (S)-ABA. In the integuments and endosperm, ABA concentration remained constant during the first 100 days after anthesis and rose in the following days when fresh weight was rapidly decreasing. In the nucellus, the ABA concentration variation pattern paralleled that of tissue growth. ABA concentration in the embryo increased constantly with the growth of the tissues to reach a maximum at the last growth stage. The role of ABA in peach seeds is discussed in relation to the development of the different seed tissues.
Growth of the peach fruit occurs in three stages, as shown by Connors (4) : rapid growth (stage I), delayed growth (stage II), and second rapid growth (stage III). The growth of the nucellus and integuments during stage I is parallel to the rapid growth ofthe pericarp, while embryo development is arrested. At the beginning of stage II (delayed development of the pericarp), the nucellus and integuments enter a period of delayed development, and the endosperm begins a rapid enlargement. During stage III, the nucellus degenerates and the embryo begins its development; depending on the variety, it reaches maximum size during this period.
The endogenous systems that regulate this growth pattern are not known, but several scientists have described a regulating role played by hormones. A high content of gibberellins has been observed during peach seed development (6, 17, 18) . Ethylene production also occurs at relatively high rates and, at the same time, 1 -aminocyclopropane-1 -carboxylic acid concentration peaks in the fruit (8, 10) . Auxin level is also high during seed development, as shown by Miller et al. (1 1). Few data are available on ABA content in peach seeds (2) and particularly on ABA quantification in the various seed components during development.
The availability of immunological methods for the quantification of ABA allows accurate analysis of ABA content over a great number of samples in much less time compared with the more traditional gas-chromatographic analysis. In fact, ABA content in the various tissues during seed development has been thoroughly measured in recent investigations carried out on Sechium edule (15) and Phaseolus coccineus (12) .
In this paper, we report on the quantitation of ABA in integuments, nucellus, endosperms, and embryos of Prunus persica cv Springcrest during seed development, with the aim of extending information on the hormonal relation between these seed components.
MATERIALS AND METHODS

Plant Material
Developing fruits of peach (Prunus persica cv Springcrest), were harvested in the open field from May to June 1990. Care was taken to spread the sampling over the trees so that it would not drastically alter the crop load of any tree. Fruits were opened and seed tissues were dissected under a stereoscopic microscope. The material was weighed and immediately frozen in liquid nitrogen.
Extraction
Isolated seed tissues were extracted separately in distilled water for 16 h at 4°C in the dark, and the aqueous extract, appropriately diluted, was used for RIA' analysis. Water extraction efficiency for ABA has been reported to be more than 95% (9, 14 
RESULTS
The growth pattern of single components of the peach seed is shown in Figure 1 . The growth period of both integuments and nucellus is relatively short and characterized by a very high growth rate. Immediately after its period of maximal growth, degeneration of the nucellus takes place and growth of both endosperm and embryo begins. Fruit ripening parallels the embryo growth.
The HPLC experiments (Fig. 2) showed the presence of immunoreactive material in the fraction with the same elution volume as ABA and in other fractions, indicating the presence of immunoreactive compounds other than ABA in crude aqueous extracts of all the four tissues under investigation.
To verify whether these compounds could originate from ABA during the 16 h extraction period, ['4C]ABA was added to the tissue prior to extraction, and after the extraction period the extract was fractionated by HPLC. No radioactive material other than ABA was found in any HPLC fraction, indicating that the cross-reacting compounds are present in the tissue and do not originate from ABA conversion during the extraction period (Fig. 3) .
The presence of immunoreactive materials other than ABA in peach seed crude aqueous extracts required an HPLC purification step prior to RIA analysis. Therefore, ABA quantification was carried out after HPLC fractionation of the crude extracts by analyzing ABA content in the fraction with the same elution volume as ABA.
ABA content in the individual tissues is reported in Figures  4 and 5 for unit of weight and per organ, respectively. ABA concentration in the integuments remained constant during the first four growth stages, but showed a rapid increase in the last stage. In embryos, ABA concentration increased with the growth ofthe tissue to reach a maximum at the last growth stage. The pattern in the endosperm was intermediate between that in the integuments and in the embryos. In the nucellus, the level of ABA increased with the growth of the tissues, but decreased drastically (concomitantly) with tissue degeneration.
ABA content per organ (Fig. 5 ) increased during the period of integument growth, but subsequently remained constant. ABA elution volum-re (ml) Figure 3 . Distribution of radioactivity on HPLC fractionated crude aqueous extract of whole peach seed fed with 14C-labeled ABA. Dennis (2) . However, these differences could derive from the use of different cultivars of peach. A noticeable increase in ABA levels during the last developmental stages was also observed in Phaseolus coccineus seeds ( 12) .
ABA accumulation during late stages of development could prevent precocious germination of seeds. Moreover it could be involved in the regulation of storage protein synthesis, as indicated by other works (3, 5, 13) .
As concerns the unknown cross-reacting compound, we have no information about its molecular structure. However, the monoclonal antibody used has strict requirements for the binding activity and, in fact, it shows very low cross-reactivity with the main ABA metabolites, (phaseic and dihydrophaseic acid) (14) . Moreover, DBPA1 was tested with synthetic analogs of ABA (16) and its high specificity characteristics were confirmed. Therefore, the unknown cross-reacting compound found in the present work should be structurally very similar to ABA. Hence, we cannot exclude that it can be an unknown metabolite or precursor of ABA. Further work is needed to verify this possibility, looking for an eventual physiological role of this substance.
